About Biosidus

Biosidus is a global company making a difference in millions of patients’ lives around the world by providing access in emerging markets to complex biological drugs that effectively treat chronic medical conditions and rare or life-threatening diseases.

Biosimilars are similar in structure and function to reference biological drugs on which they are based. The patents on the originals have expired so the biosimilars can provide similarly efficacious treatment at lower costs. Over 30 years, Biosidus’ R&D team have developed nine biosimilars that are commercially manufactured at our fully integrated Almagro drug substance and Bernal drug product fill-finish facilities in Buenos Aires, Argentina.

Biosidus has also signed licensing agreements with large pharmaceutical companies to supplement our own portfolio with other third-party biological drugs, and we distribute products across a large network of emerging markets – bringing essential treatments to the large populations who need them.

Our Regulatory Affairs and Pharmacovigilance Department covers the regulatory requirements for approved products in more than 40 countries and ongoing registration procedures in another 20 countries. We have an excellent track record of quality, and products in various formulations and formats are distributed from our logistics center in Buenos Aires to over 60 countries worldwide.

We have a highly talented team that is extremely proud of our company and the difference we make to quality of life for tens of millions of patients in emerging markets around the world.

OUR VISION

Biosidus wants to be the leader in biosimilars in developing countries.

OUR MISSION

“We want to contribute to the improvement in people’s health and quality of life by developing and manufacturing drug products that meet international standards of quality.”

History

CORPORATE GOVERNANCE

Board of directors

Biosidus Group has a Board of Directors comprising seven experienced members, including independent directors.

Auditing & risks committee

This committee is composed of three members of the Board of Directors. The group assesses and supervises the control system efficiency in order to ensure the successful achievement of goals and strategies set by the Board of Directors, operational effectiveness, the reliability of financial data and information, and compliance with relevant laws and regulations.

Compensations committee

This committee also comprises three members of the Board of Directors. Their responsibilities include analyzing, assessing and proposing standards and strategic projects associated with growth in human capital at Biosidus.

Executive Committee

This committee comprises 11 members, including the CEO and his direct reports, who take responsibility for management of the following areas:

OUR ACHIEVEMENTS

We have good practices in safety and hygiene and environmental health.

Almagro

Research, development and manufacturing of raw materials resulting from biotechnologies, with a warehouse and a quality control laboratory in the Ciudad Autónoma de Buenos Aires plant.

IQNET CERTIFICATE

Research, development and manufacturing of raw materials resulting from biotechnologies, with a warehouse and a quality control laboratory in the Ciudad Autónoma de Buenos Aires plant.

IQNET CERTIFICATE
Bernal & Quilmes

Development of medical products presented in a formulation as injectable lyophilized liquids that include biotechnological active substances and not beta-lactam, cytostatic or hormonal active substances. Manufacturing of glass vials with diluents that include secondary package and quality control. Exportation of medical specialties. Activities carried out in the Bernal plant.

IQNET CERTIFICATE

Development of medical specialties presented in a formulation as injectable lyophilized liquids that include biotechnological active substances and not beta-lactam, cytostatic or hormonal active substances. Manufacturing of glass vials with diluents that include secondary package and quality control. Exportation of medical specialties. Activities carried out in the Bernal plant.

IQNET CERTIFICATE
/ Certificates

We have become part of the United Nations Women program “Ganar-Ganar” (Win-Win)

Women’s economic empowerment is at the core of the United Nations Women agenda. The concept does not only mean that women should have their own income, but that they should also have control over those resources, and the ability to make their own choices and decisions in processes whereby people raise awareness of their rights, abilities and interests.

/ Certificados

FLOR Awards – We were finalists in the Big Companies category

We were finalists as a result of our practices. The aspects that were taken into account were:
Diversity practice integration in the management, internal policies on diversity management and multiplying the action in the society.